Journal Home > Volume 15 , Issue 9
Nano Research 2022, 15(9): 8247-8254 https://doi.org/10.1007/s12274-022-4454-8
Research Article | Issue | Published: 12 June 2022

Ascorbic acid derived carbon dots promote circadian rhythm and contribute to attention deficit hyperactivity disorder

Show Author's Information Jian Huang1,  Yun Wang1,  Zhaomin Zhong1,  Yurong Ma2,  Keru Deng1,  Changhong Liu1,  Hui Huang2,  Yang Liu2( ),  Xin Ding3( ),  Zhenhui Kang2,4( )
School of Biology & Basic Medical Science, Soochow University, Suzhou 215123, China
Institute of Functional Nano and Soft Materials Laboratory (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, Suzhou 215123, China
Division of Neonatology, Children’s Hospital of Soochow University, Suzhou 215003, China
Macao Institute of Materials Science and Engineering (MIMSE), MUST-SUDA Joint Research Center for Advanced Functional Materials, Macau University of Science and Technology, Taipa 999078, Macao, China
Keywords:
circadian rhythm, dopamine, carbon dots, zebrafish, attention deficit hyperactivity disorder (ADHD)
Topics:
Nano biology
Cite this article:
Huang J, Wang Y, Zhong Z, et al. Ascorbic acid derived carbon dots promote circadian rhythm and contribute to attention deficit hyperactivity disorder. Nano Research, 2022, 15(9): 8247-8254. https://doi.org/10.1007/s12274-022-4454-8
Download citation
EndNote(RIS)
BibTeX

631

Views

49

Downloads

Citations

4

Crossref

3

WoS

3

Scopus

0

CSCD

Abstract Full text Electronic supplementary material About this article

Attention deficit hyperactivity disorder (ADHD) is one of the most prevalent psychiatric disorders in children, and ADHD patients always display circadian abnormalities. While, the ADHD drugs currently used in clinic have strong side effects, such as psychosis, allergic reactions, and heart problems. Here, we demonstrated carbon dots derived from the ascorbic acid (VCDs) could strongly rescue the hyperactive and impulsive behaviour of a zebrafish ADHD disease model caused by per1b mutation. VCDs prolonged the circadian period of zebrafish for more than half an hour. In addition, the amplitude and circadian phase were also changed. The dopamine level was specifically increased, which may be caused by stimulation of the dopaminergic neuron development in the midbrain. Notably, it was found that the serotonin level was not altered by VCDs treatments. Also, the gene transcriptome effects of VCDs were discussed in present work. Our results provided the dynamic interactions of carbon dots with circadian system and dopamine signaling pathway, which illustrates a potential application of degradable and bio-safe VCDs for the treatment of the attention deficient and hyperactive disorder through circadian intervention.


menu
Abstract
Full text
Outline
Electronic supplementary material
About this article

Ascorbic acid derived carbon dots promote circadian rhythm and contribute to attention deficit hyperactivity disorder

Show Author's information Jian Huang1, Yun Wang1, Zhaomin Zhong1, Yurong Ma2, Keru Deng1, Changhong Liu1, Hui Huang2, Yang Liu2( ), Xin Ding3( ), Zhenhui Kang2,4( )
School of Biology & Basic Medical Science, Soochow University, Suzhou 215123, China
Institute of Functional Nano and Soft Materials Laboratory (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, Suzhou 215123, China
Division of Neonatology, Children’s Hospital of Soochow University, Suzhou 215003, China
Macao Institute of Materials Science and Engineering (MIMSE), MUST-SUDA Joint Research Center for Advanced Functional Materials, Macau University of Science and Technology, Taipa 999078, Macao, China

Abstract

Attention deficit hyperactivity disorder (ADHD) is one of the most prevalent psychiatric disorders in children, and ADHD patients always display circadian abnormalities. While, the ADHD drugs currently used in clinic have strong side effects, such as psychosis, allergic reactions, and heart problems. Here, we demonstrated carbon dots derived from the ascorbic acid (VCDs) could strongly rescue the hyperactive and impulsive behaviour of a zebrafish ADHD disease model caused by per1b mutation. VCDs prolonged the circadian period of zebrafish for more than half an hour. In addition, the amplitude and circadian phase were also changed. The dopamine level was specifically increased, which may be caused by stimulation of the dopaminergic neuron development in the midbrain. Notably, it was found that the serotonin level was not altered by VCDs treatments. Also, the gene transcriptome effects of VCDs were discussed in present work. Our results provided the dynamic interactions of carbon dots with circadian system and dopamine signaling pathway, which illustrates a potential application of degradable and bio-safe VCDs for the treatment of the attention deficient and hyperactive disorder through circadian intervention.

Keywords: circadian rhythm, dopamine, carbon dots, zebrafish, attention deficit hyperactivity disorder (ADHD)

References(32)

1

Flores-Dourojeanni, J. P.; Van Rijt, C.; Van Den Munkhof, M. H.; Boekhoudt, L.; Luijendijk, M. C. M.; Vanderschuren, L.; Adan, R. A. H. Temporally specific roles of ventral tegmental area projections to the nucleus accumbens and prefrontal cortex in attention and impulse control. J. Neurosci. 2021, 41, 4293–4304.
DOI Google Scholar
2

Mikkelsen, S. H.; Olsen, J.; Bech, B. H.; Wu, C. S.; Liew, Z.; Gissler, M.; Obel, C.; Arah, O. A. Birth asphyxia measured by the pH value of the umbilical cord blood may predict an increased risk of attention deficit hyperactivity disorder. Acta Paediatr. 2017, 106, 944–952.
DOI Google Scholar
3

Wiesner, C. D.; Molzow, I.; Prehn-Kristensen, A.; Baving, L. Sleep-dependent consolidation of rewarded behavior is diminished in children with attention deficit hyperactivity disorder and a comorbid disorder of social behavior. Front. Psychol. 2017, 8, 167.
DOI Google Scholar
4

Kendall, T.; Taylor, E.; Perez, A.; Taylor, C. Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: Summary of NICE guidance. BMJ 2008, 337, a1239.
DOI Google Scholar
5

Rosler, M.; Retz, W.; Retz-Junginger, P.; Hengesch, G.; Schneider, M.; Supprian, T.; Schwitzgebel, P.; Pinhard, K.; Dovi-Akue, N.; Wender, P. et al. Prevalence of attention deficit-/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates. Eur. Arch. Psychiatry Clin. Neurosci. 2004, 254, 365–371.
DOI Google Scholar
6

Huang, H.; Yang, S. W.; Liu, Y.; Yang, Y. C.; Li, H.; McLeod, J. A.; Ding, G. Q.; Huang, J.; Kang, Z. H. Photocatalytic polymerization from amino acid to protein by carbon dots at room temperature. ACS Appl. Bio Mater. 2019, 2, 5144–5153.
DOI Google Scholar
7
Wang, Y.; Kessel, E.; Lee, S.; Hong, S.; Raffanello, E.; Hulvershorn, L. A.; Margolis, A.; Peterson, B. S.; Posner, J. Causal effects of psychostimulants on neural connectivity: A mechanistic, randomized clinical trial. J. Child Psychol. Psychiatry, in press, https://doi.org/10.1111/jcpp.13585.
8

Capuzzi, E.; Capellazzi, M.; Caldiroli, A.; Cova, F.; Auxilia, A. M.; Rubelli, P.; Tagliabue, I.; Zanvit, F. G.; Peschi, G.; Buoli, M. et al. Screening for ADHD Symptoms among Criminal Offenders: Exploring the Association with Clinical Features. Healthcare 2022, 10, 180.
DOI Google Scholar
9

Lieschke, G. J.; Currie, P. D. Animal models of human disease: Zebrafish swim into view. Nat. Rev. Genet. 2007, 8, 353–367.
DOI Google Scholar
10

Huang, J.; Zhong, Z. M.; Wang, M. Y.; Chen, X. F.; Tan, Y. C.; Zhang, S. Q.; He, W.; He, X.; Huang, G. D.; Lu, H. P. et al. Circadian modulation of dopamine levels and dopaminergic neuron development contributes to attention deficiency and hyperactive behavior. J. Neurosci. 2015, 35, 2572–2587.
DOI Google Scholar
11

Whalley, K. A zebrafish model of ADHD. Nat. Rev. Neurosci. 2015, 16, 188.
DOI Google Scholar
12

Xue, X.; Yang, J. Y.; He, Y.; Wang, L. R.; Liu, P.; Yu, L. S.; Bi, G. H.; Zhu, M. M.; Liu, Y. Y.; Xiang, R. W. et al. Aggregated single-walled carbon nanotubes attenuate the behavioural and neurochemical effects of methamphetamine in mice. Nat. Nanotechnol. 2016, 11, 613–620.
DOI Google Scholar
13

Kim, D.; Yoo, J. M.; Hwang, H.; Lee, J.; Lee, S. H.; Yun, S. P.; Park, M. J.; Lee, M.; Choi, S.; Kwon, S. H.; Lee, S.; Kwon, S. H. et al. Graphene quantum dots prevent α-synucleinopathy in Parkinson's disease. Nat. Nanotechnol. 2018, 13, 812–818.
DOI Google Scholar
14

Black, N.; Stockings, E.; Campbell, G.; Tran, L. T.; Zagic, D.; Hall, W. D.; Farrell, M.; Degenhardt, L. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: A systematic review and meta-analysis. Lancet Psychiatry 2019, 6, 995–1010.
DOI Google Scholar
15

Hua, Y. F.; Wang, C.; Huang, J.; Wang, K. J. A simple and efficient method for CRISPR/Cas9-induced mutant screening. J. Genet. Genom. 2017, 44, 207–213.
DOI Google Scholar
16

Liu, A. N.; Xu, Y. W.; Yan, Q.; Tong, L. The prevalence of attention deficit/hyperactivity disorder among Chinese children and adolescents. Sci. Rep. 2018, 8, 11169.
DOI Google Scholar
17

Garner, I.; Vichare, R.; Paulson, R.; Appavu, R.; Panguluri, S. K.; Tzekov, R.; Sahiner, N.; Ayyala, R.; Biswal, M. R. Carbon dots fabrication: Ocular imaging and therapeutic potential. Front. Bioeng. Biotechnol. 2020, 8, 573407.
DOI Google Scholar
18

Posner, J.; Polanczyk, G. V.; Sonuga-Barke, E. Attention-deficit hyperactivity disorder. Lancet 2020, 395, 450–462.
DOI Google Scholar
19

Li, H.; Huang, J.; Song, Y. X.; Zhang, M. L.; Wang, H. B.; Lu, F.; Huang, H.; Liu, Y.; Dai, X.; Gu, Z. L. et al. Degradable carbon dots with broad-spectrum antibacterial activity. ACS Appl. Mater. Interfaces 2018, 10, 26936–26946.
DOI Google Scholar
20

Li, H.; Huang, J.; Liu, Y.; Lu, F.; Zhong, J.; Wang, Y.; Li, S. M.; Lifshitz, Y.; Lee, S. T.; Kang, Z. H. Enhanced RuBisCO activity and promoted dicotyledons growth with degradable carbon dots. Nano Res. 2019, 12, 1585–1593.
DOI Google Scholar
21

VanGuilder, H. D.; Vrana, K. E.; Freeman, W. M. Twenty-five years of quantitative PCR for gene expression analysis. BioTechniques 2008, 44, 619–626.
DOI Google Scholar
22

Grabherr, M. G.; Haas, B. J.; Yassour, M.; Levin, J. Z.; Thompson, D. A.; Amit, I.; Adiconis, X.; Fan, L.; Raychowdhury, R.; Zeng, Q. D. et al. Full-length transcriptome assembly from RNA-Seq data without a reference genome. Nat. Biotechnol. 2011, 29, 644–652.
DOI Google Scholar
23

Yu, Y.; Sun, H. Y.; Gilmore, K.; Hou, T. J.; Wang, S. D.; Li, Y. Y. Aggregated single-walled carbon nanotubes absorb and deform dopamine-related proteins based on molecular dynamics simulations. ACS Appl. Mater. Interfaces 2017, 9, 32452–32462.
DOI Google Scholar
24

Bolyard, K. J.; Rowland, W. J. Context-dependent response to red coloration in stickleback. Anim. Behav. 1996, 52, 923–927.
DOI Google Scholar
25

Burns, G. L.; Walsh, J. A.; Servera, M.; Lorenzo-Seva, U.; Cardo, E.; Rodriguez-Fornells, A. Construct validity of ADHD/ODD rating scales: Recommendations for the evaluation of forthcoming DSM-V ADHD/ODD scales. J. Abnorm. Child Psychol. 2013, 41, 15–26.
DOI Google Scholar
26

Gong, R.; Ding, C.; Hu, J.; Lu, Y.; Liu, F.; Mann, E.; Xu, F. Q.; Cohen, M. B.; Luo, M. M. Role for the membrane receptor guanylyl cyclase-C in attention deficiency and hyperactive behavior. Science 2011, 333, 1642–1646.
DOI Google Scholar
27

Hanswijk, S. I.; Spoelder, M.; Shan, L.; Verheij, M. M. M.; Muilwijk, O. G.; Li, W. Z.; Liu, C. Q.; Kolk, S. M.; Homberg, J. R. Gestational factors throughout fetal neurodevelopment: The serotonin link. Int. J. Mol. Sci. 2020, 21, 5850.
DOI Google Scholar
28

Bornstein, R. A.; Baker, G. B.; Carroll, A.; King, G.; Wong, J. T. F.; Douglass, A. B. Plasma amino acids in attention deficit disorder. Psychiatry Res. 1990, 33, 301–306.
DOI Google Scholar
29

Ryu, S.; Mahler, J.; Acampora, D.; Holzschuh, J.; Erhardt, S.; Omodei, D.; Simeone, A.; Driever, W. Orthopedia homeodomain protein is essential for diencephalic dopaminergic neuron development. Curr. Biol. 2007, 17, 873–880.
DOI Google Scholar
30

Lange, M.; Norton, W.; Coolen, M.; Chaminade, M.; Merker, S.; Proft, F.; Schmitt, A.; Vernier, P.; Lesch, K. P.; Bally-Cuif, L. The ADHD-susceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development. Mol. Psychiatry 2012, 17, 946–954.
DOI Google Scholar
31

Arcos-Burgos, M.; Jain, M.; Acosta, M. T.; Shively, S.; Stanescu, H.; Wallis, D.; Domené, S.; Vélez, J. I.; Karkera, J. D.; Balog, J. et al. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol. Psychiatry 2010, 15, 1053–1066.
DOI Google Scholar
32

Tay, T. L.; Ronneberger, O.; Ryu, S.; Nitschke, R.; Driever, W. Comprehensive catecholaminergic projectome analysis reveals single-neuron integration of zebrafish ascending and descending dopaminergic systems. Nat. Commun. 2011, 2, 171.
DOI Google Scholar
File
12274_2022_4454_MOESM1_ESM.pdf (618.8 KB)
Publication history
Copyright
Acknowledgements

Publication history

Received: 07 March 2022
Revised: 18 April 2022
Accepted: 20 April 2022
Published: 12 June 2022
Issue date: September 2022

Copyright

© Tsinghua University Press 2022

Acknowledgements

Acknowledgements

This work was supported by the National Natural Science Foundation of China (Nos. 31671216, 81871193, 51725204, 21771132, 51972216, and 52041202), the National MCF Energy R&D Program of China (No. 2018YFE0306105), the National Key R&D Program of China (Nos. 2020YFA0406104 and 2020YFA0406101), Innovative Research Group Project of the National Natural Science Foundation of China (No. 51821002), Natural Science Foundation of Jiangsu Province (No. BK20190041), National College Students Innovation and Entrepreneurship Training Program (No. 201710285042Z), Suzhou Scientific Program (No. SS202074), Key R&D program of Ningxia Hui Autonomous Region (No. 2022BEG02006), Ningxia Autonomous Region flexible introduction of science and technology innovation team (No. 2021RXTDLX08), Agricultural science and technology innovation project of Suzhou Science and Technology Development Plan (No. SNG2020074), Collaborative Innovation Center of Suzhou Nano Science & Technology, the 111 Project, and Suzhou Key Laboratory of Functional Nano & Soft Materials.

Return